Back to search

Netherlands· NL-6d3a1f86282a

Granisetron Aurobindo 2 mg, filmomhulde tabletten

A granisetron product containing granisetronhydrochloride, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC A04AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGranisetron Aurobindo 2 mg, filmomhul…ATCA04AA02REGISTER NO.NL-6d3a1f86282aPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Granisetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA02 (granisetron), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Granisetron · ATC A04AA02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of granisetron costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $10.02 in Italy to $29.01 in Switzerland — a ×2.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Granisetron · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$29.01
  • FR France$11.60
  • IT Italy$10.02
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GRANISETRONHYDROCHLORIDE
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
A04AA02
ATC class
Granisetron
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    103031

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

564 interactions on record for granisetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Granisetron · interactions on record

564 records

  • 139 severe
  • 244 moderate
  • 9 minor
  • 172 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Granisetron in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All granisetron products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Granisetron Actavis, Kytril
  • Belgium · Granisetron Fresenius Kabi, Kytril
  • Bulgaria · Расетрон
  • Czechia · Granegis, Granisetron Kabi
  • Germany · Grani, Granisetron Baxter
  • Denmark · Granisetron Hameln, Granisetron Stada
  • Estonia · Kytril
  • Spain · Granisetrón Altan, Granisetrón Aurovitas Spain
  • Finland · Gazoron, Granisetron Baxter
  • France · Kytril
  • United Kingdom (Northern Ireland) · Granisetron, Granisetron Dawa
  • Greece · Granitron, Viatrinil 1mg/Ml
  • Croatia · Granizetron Kabi
  • Hungary · Granegis, Granigen
  • Ireland · Kytril
  • Iceland · Grandise, Granem
  • Italy · Grandise, Granem
  • Liechtenstein · Sancuso
  • Malta · Granisetron Sigillata
  • Norway · Sancuso
  • Portugal · Granisetron Orchid Europe, Granissetrom Aurovitas
  • Romania · Granisetron Kabi, Granisetron Labormed
  • Sweden · Granisetron Fresenius Kabi, Granisetron Hameln
  • Slovenia · Granisetron Lek, Kytril
  • Slovakia · Emegar, Granegis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/02a04512-e7f8-4a97-abb1-dac5cad91ec5
GET /v1/drugs/02a04512-e7f8-4a97-abb1-dac5cad91ec5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103031_smpc.pdf",
  "strength": null,
  "atc_label": "Granisetron",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg103031",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 0-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "GRANISETRONHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h103031.pdf",
  "authorised_at": "2009/03/30",
  "procedure_number": "NL/H/4309/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "103031",
  "additional_monitoring": "N"
}

See everything about granisetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.